Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
QuantumPharm, Inc. ( (HK:2228) ) has provided an update.
XtalPi Holdings Limited has successfully completed the placement of 264 million new shares under a general mandate, generating approximately HK$1,125 million in net proceeds. This placement increases the company’s issued share capital by about 7.18% and involves investment from professional and institutional investors, potentially strengthening XtalPi’s market position and financial resources.
More about QuantumPharm, Inc.
XtalPi Holdings Limited, formerly known as QuantumPharm Inc., is a company incorporated in the Cayman Islands with limited liability. It operates within the pharmaceutical industry, focusing on innovative drug discovery and development, leveraging computational methods to enhance its research processes.
YTD Price Performance: -18.39%
Average Trading Volume: 88,507,579
Technical Sentiment Consensus Rating: Strong Buy
For detailed information about 2228 stock, go to TipRanks’ Stock Analysis page.